Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition

Annamaria Rapisarda(Frederick National Laboratory for Cancer Research), Giovanni Melillo(Science Applications International Corporation (United States))
Molecular Cancer Therapeutics
July 1, 2009
Cited by 170


Related Papers